DuChemBIO Co.,Ltd. (KOSDAQ:176750)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
Manufacturing and Sales of Radiopharmaceuticals and Related Medical Devices	34.70B
Total	34.70B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec 31, 2023
South Korea	34.59B
North America	59.79M
Oceania	13.28M
Asia	30.72M
Total	34.70B

Source: S&P Global Market Intelligence.